X0306 4 2023-02-22 0 0001618756 Restaurant Brands International Inc. QSR 0001829353 Siddiqui Sami A. 5707 BLUE LAGOON DRIVE MIAMI FL 33126 0 1 0 0 Brand Pres., Popeyes, Americas Common Shares 2023-02-22 4 A 0 2373 67.75 A 11643.8364 D Common Shares 131634 I By Trust Option (Right to Buy) 55.55 2027-02-23 Common Shares 80000 80000 D Option (Right to Buy) 66.31 2025-02-21 2030-02-20 Common Shares 20000 20000 D Restricted Share Units Common Shares 6604.4107 6604.4107 D Restricted Share Units Common Shares 8021.4963 8021.4963 D Performance Share Units 2024-02-22 2024-02-22 Common Shares 57670.3697 57670.3697 D Performance Share Units 2025-02-21 2025-02-21 Common Shares 22397.0301 22397.0301 D Performance Share Units 2025-02-21 2025-02-21 Common Shares 21666.5333 21666.5333 D Restricted Share Units Common Shares 4725.2644 4725.2644 D Restricted Share Units Common Shares 5515.6723 5515.6723 D Performance Share Units 2024-02-19 2024-02-19 Common Shares 28781.1559 28781.1559 D Restricted Share Units Common Shares 6741.5259 6741.5259 D Performance Share Units 2025-02-25 2025-02-25 Common Shares 41001.5473 41001.5473 D Restricted Share Units 2023-02-22 4 A 0 8902 0.00 A Common Shares 8902 8902 D Performance Share Units 2023-02-22 4 A 0 36900 0.00 A 2026-02-22 2026-02-22 Common Shares 36900 36900 D The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2022 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2022 net bonus to purchase common shares at a purchase price of $67.75 per share ("Investment Shares"). Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 17 below pursuant to the Issuer's 2022 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 21, 2023. Reflects the transfer of 5,774 shares previously held directly by the Reporting Person to a revocable trust in a transaction exempt from reporting pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. These shares are held by a revocable trust, of which the Reporting Person is the settlor and trustee for the benefit of the Reporting Person. These options are immediately exercisable. Each restricted share unit represents a contingent right to receive one common share. These restricted share units vest on December 31, 2023. These restricted share units vest on December 31, 2024. The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. The shares reported represent an award of performance based restricted share units ("2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. The Issuer granted the 2023 restricted share units ("2023 RSUS") to the Reporting Person pursuant to the Issuer's 2022 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2022 net bonus to purchase Investment Shares and received a matching grant of 2023 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $67.75 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2023 RSUs that have not yet vested. These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. /s/ Michele Keusch, as Attorney-in-Fact for Sami A. Siddiqui 2023-02-24